Nanopharm
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Franklin House Grange Rd, NP44 3WY, Unit...Phone Number
+44 1633372200Website
www.nanopharm.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanopharm
Nanopharm specializes in the development of inhaled and nasal drug delivery products, offering integrated analytical services and proprietary in-vitro in-silico modeling systems to demonstrate bioequivalence. Their expertise spans various drug delivery formats for both small molecules and biologics, catering to innovator, generic, and lifecycle management applications. With over 20 years of experience, they provide comprehensive support from early development through to clinical stages and commercialization. Nanopharm is also committed to sustainability, researching low Global Warming Potential propellants for inhalers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nanopharm launches new products
Website visits: Recent activity has been detected on your website
Check if Nanopharm has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nanopharm recently announced quarterly report
Funding: Get notified immidiatlly once Nanopharm has new funding data
Click to see if Nanopharm had a recent Job posting/layoffs
Nanopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nanopharm
Check out if Nanopharm is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Nanopharm as Masked Content
Find 3 more new buyers
Compare Similar Companies to Nanopharm
Compare insights from companies similar to Nanopharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nanopharm
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Nanopharm is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nanopharm is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nanopharm.
Nanopharm Tech Stack
A closer look at the technologies used by Nanopharm
See more technologies
Nanopharm News & Media
Nanopharm and Leyden Labs Announce Agreement to Develop Intranasal Spray Product Candidates for Prophylactic Use Against Known and New Respiratory Viruses
NEWPORT, United Kingdom and AMSTERDAM, July 21, 2021 (GLOBE NEWSWIRE) -- Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and nasally delivered drug products (OINDP) and Leyden Labs, a company targeting commonalities of viral families to protect humanity from known and future viruses, today announced that they have entered into an agreement to develop nasal sprays that may provide broad protection against respiratory viruses, combining LeyAptar Acquires Nanopharm and Gateway Analytical, for Approx. $50M
Crystal Lake, Illinois-based AptarGroup, Inc. (NYSE: ATR) acquired Nanopharm Ltd. and Gateway Analytical LLC, two pharmaceutical services companies, for a combined enterprise value of approximately $50m. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments. Both acquisitions […] The post Aptar Acquires Nanopharm and Gateway Analytical, for Approx. $50M appeaAptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments. Both acquisitions bring complementary, value-added and differe
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanopharm
Sign Up For FreeTo access detailed company insights
Nanopharm specializes in the development of inhaled and nasal drug delivery products, offering integrated analytical services and proprietary in-vitro in-silico modeling systems to demonstrate bioequivalence. Their expertise spans various drug delivery formats for both small molecules and biologics, catering to innovator, generic, and lifecycle man... Read More
